Sundar Sankaran
About Sundar Sankaran
Data last updated:
Sundar Sankaran is a Nominee Director at Shalina Laboratories Private Limited (since 2020), Director at Nj Trustee Private Limited (since 2020) and Director at Shalina Trading Co Pvt Ltd (since 2011), and holds 2 more current directorships. The companies operate in Pharma, Financial Services and Chemicals and Materials. The 4 current companies with reported revenue have a combined latest revenue of ₹545 Cr; the largest is Shalina Laboratories Private Limited at ₹544 Cr (FY 2025). Earlier, Sundar Sankaran was a Director at Bekandze Healthcare Private Limited (2010–2014) and Director at Mavuca Capital Advisors Private Limited (2018–2022) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shalina Laboratories Private Limited U33100MH2020FTC344984 | Nominee Director | 31 Aug 2020 | 2020 | ₹544 Cr (FY 2025) | Active |
 Nj Trustee Private Limited U65929MH2020PTC343074 | Director | 06 Oct 2020 | 2020 | ₹27.1 Lakh (FY 2025) | Active |
 Shalina Trading Co Pvt Ltd U51900MH1981PTC024779 | Director | 12 Mar 2011 | 1981 | ₹7.7 Lakh (FY 2025) | Active |
 Advantage-India Consulting Private Limited U74140MH1999PTC123288 | Director | 24 Dec 1999 | 1999 | ₹3.4 Lakh (FY 2024) | Active |
 Shalina Pharmaceuticals Private Limited U24299MH2021PTC364251 | Nominee Director | 20 Jul 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Bekandze Healthcare Private Limited U24240MH2010PTC207751 | Director | 16 Sep 2010 | 2010 | Strike Off | |
 Mavuca Capital Advisors Private Limited U74999MH2018PTC318444 | Director | 18 Dec 2018 | 2018 | ₹6.11 Cr (FY 2025) | Active |
 Shalina Laboratories Private Limited U24239MH1984PTC034786 | Director | 12 Mar 2011 | 1984 | ₹551 Cr (FY 2023) | Amalgamated |
| Finberry Academy Private Limited U80301MH2008PTC178276 | Director | 25 Jan 2008 | 2008 | ₹2,500 (FY 2019) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sundar Sankaran
| Name | DIN | Company | Designation |
|---|---|---|---|
| Fazle Abbas Virji | 07085209 | Shalina Laboratories Private Limited , Shalina Pharmaceuticals Private Limited | Director |
| Prasad Shyamsunder Deshpande | 10489379 | Shalina Laboratories Private Limited , Shalina Trading Co Pvt Ltd and 1 more | Director |
| Shalina Clifford | 07085210 | Shalina Laboratories Private Limited , Shalina Pharmaceuticals Private Limited | Director |
| Sushil Kumar Agarwal | Shalina Laboratories Private Limited | Company Secretary | |
| Devesh Amubhai Pathak | 00017515 | Nj Trustee Private Limited | Director |
| Jigneshkumar Rameshchandra Desai | 00335703 | Nj Trustee Private Limited | Director |
| Mousumi Nandy | 08891042 | Nj Trustee Private Limited | Director |
| Neelam Virji | 00309142 | Shalina Trading Co Pvt Ltd | Director |
| Venkatesh Sankaran | 00012517 | Advantage-India Consulting Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sundar Sankaran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sundar Sankaran
Sundar Sankaran currently holds 5 directorships: Shalina Laboratories Private Limited (Nominee Director, since 31 Aug 2020, revenue ₹544 Cr (FY 2025)); Nj Trustee Private Limited (Director, since 06 Oct 2020, revenue ₹27.1 Lakh (FY 2025)); Shalina Trading Co Pvt Ltd (Director, since 12 Mar 2011, revenue ₹7.7 Lakh (FY 2025)); Advantage-India Consulting Private Limited (Director, since 24 Dec 1999, revenue ₹3.4 Lakh (FY 2024)); Shalina Pharmaceuticals Private Limited (Nominee Director, since 20 Jul 2021).
Sundar Sankaran was first appointed on 24 Dec 1999 as Director at Advantage-India Consulting Private Limited. The most recent appointment on record is 20 Jul 2021 at Shalina Pharmaceuticals Private Limited.
The 4 current companies of Sundar Sankaran that report revenue have a combined latest revenue of ₹545 Cr: Shalina Laboratories Private Limited ₹544 Cr (FY 2025); Nj Trustee Private Limited ₹27.1 Lakh (FY 2025); Shalina Trading Co Pvt Ltd ₹7.7 Lakh (FY 2025); Advantage-India Consulting Private Limited ₹3.4 Lakh (FY 2024).
Sundar Sankaran held 4 earlier board appointments: Bekandze Healthcare Private Limited (Director, 16 Sep 2010 to 17 Oct 2014); Mavuca Capital Advisors Private Limited (Director, 18 Dec 2018 to 16 May 2022); Shalina Laboratories Private Limited (Director, from 12 Mar 2011); Finberry Academy Private Limited (Director, from 25 Jan 2008).
The current boards of Sundar Sankaran's companies include Fazle Abbas Virji (Shalina Laboratories Private Limited), Prasad Shyamsunder Deshpande (Shalina Laboratories Private Limited), Shalina Clifford (Shalina Laboratories Private Limited), Sushil Kumar Agarwal (Shalina Laboratories Private Limited), Devesh Amubhai Pathak (Nj Trustee Private Limited), Jigneshkumar Rameshchandra Desai (Nj Trustee Private Limited), among others.